Sign in
4

Changes in Ownership

SAB Biotherapeutics, Inc. Filed Acc 0000950170-25-098365

Options or other derivatives

  • Director acquired 571,250 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Moin Andrew · Director

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2025-07-22 Grant or award : show line 1 in the form Series B Convertible Preferred Stock +228,500 228,500 I
2025-07-22 Grant or award : show line 2 in the form Warrants (right to buy) +228,500 228,500 I
2025-07-22 Grant or award : show line 3 in the form Warrants (right to buy) +114,250 114,250 I
Loading xslF345X05/ownership.xml…